vs
NOVAVAX INC（NVAX）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是NOVAVAX INC的1.3倍（$188.3M vs $147.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs 11.9%，领先36.0%），NOVAVAX INC同比增速更快（66.8% vs -21.9%），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs -15.4%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
NVAX vs RILY — 直观对比
营收规模更大
RILY
是对方的1.3倍
$147.3M
营收增速更快
NVAX
高出88.7%
-21.9%
净利率更高
RILY
高出36.0%
11.9%
两年增速更快
NVAX
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $188.3M |
| 净利润 | $17.5M | $90.3M |
| 毛利率 | 85.0% | 79.5% |
| 营业利润率 | 9.7% | 32.3% |
| 净利率 | 11.9% | 47.9% |
| 营收同比 | 66.8% | -21.9% |
| 净利润同比 | 121.6% | 1710.8% |
| 每股收益（稀释后） | $0.28 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRILY
| Q4 25 | $147.3M | $188.3M | ||
| Q3 25 | $70.4M | $215.3M | ||
| Q2 25 | $239.2M | $188.2M | ||
| Q1 25 | $666.5M | $197.2M | ||
| Q4 24 | $88.3M | $241.0M | ||
| Q3 24 | $84.5M | $225.5M | ||
| Q2 24 | $415.5M | $256.0M | ||
| Q1 24 | $93.9M | $263.4M |
净利润NVAXRILY
| Q4 25 | $17.5M | $90.3M | ||
| Q3 25 | $-202.4M | $91.1M | ||
| Q2 25 | $106.5M | $139.5M | ||
| Q1 25 | $518.6M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $-121.3M | $-284.4M | ||
| Q2 24 | $162.4M | $-433.6M | ||
| Q1 24 | $-147.6M | $-49.2M |
毛利率NVAXRILY
| Q4 25 | 85.0% | 79.5% | ||
| Q3 25 | 69.5% | 83.7% | ||
| Q2 25 | 93.6% | 81.3% | ||
| Q1 25 | 97.9% | 81.4% | ||
| Q4 24 | 58.5% | 79.8% | ||
| Q3 24 | 28.3% | 82.1% | ||
| Q2 24 | 88.9% | 84.5% | ||
| Q1 24 | 36.9% | 85.3% |
营业利润率NVAXRILY
| Q4 25 | 9.7% | 32.3% | ||
| Q3 25 | -252.7% | 30.4% | ||
| Q2 25 | 42.2% | 5.7% | ||
| Q1 25 | 77.4% | -31.2% | ||
| Q4 24 | — | -69.2% | ||
| Q3 24 | -158.6% | -36.4% | ||
| Q2 24 | 38.7% | -90.8% | ||
| Q1 24 | -154.3% | -6.1% |
净利率NVAXRILY
| Q4 25 | 11.9% | 47.9% | ||
| Q3 25 | -287.3% | 42.3% | ||
| Q2 25 | 44.5% | 74.1% | ||
| Q1 25 | 77.8% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | -143.5% | -126.1% | ||
| Q2 24 | 39.1% | -169.4% | ||
| Q1 24 | -157.2% | -18.7% |
每股收益（稀释后）NVAXRILY
| Q4 25 | $0.28 | $2.78 | ||
| Q3 25 | $-1.25 | $2.91 | ||
| Q2 25 | $0.62 | $4.50 | ||
| Q1 25 | $2.93 | $-0.39 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-0.76 | $-9.39 | ||
| Q2 24 | $0.99 | $-14.35 | ||
| Q1 24 | $-1.05 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-127.8M | $-171.5M |
| 总资产 | $1.2B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVAXRILY
| Q4 25 | $735.1M | $226.6M | ||
| Q3 25 | $762.9M | $184.2M | ||
| Q2 25 | $612.3M | $267.4M | ||
| Q1 25 | $731.5M | $138.3M | ||
| Q4 24 | $923.1M | $146.9M | ||
| Q3 24 | $909.5M | $159.2M | ||
| Q2 24 | $1.0B | $236.9M | ||
| Q1 24 | $480.6M | $190.7M |
总债务NVAXRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NVAXRILY
| Q4 25 | $-127.8M | $-171.5M | ||
| Q3 25 | $-156.7M | $-260.5M | ||
| Q2 25 | $37.6M | $-351.7M | ||
| Q1 25 | $-75.6M | $-496.8M | ||
| Q4 24 | $-623.8M | $-488.2M | ||
| Q3 24 | $-526.4M | $-497.6M | ||
| Q2 24 | $-431.7M | $-218.3M | ||
| Q1 24 | $-867.1M | $228.4M |
总资产NVAXRILY
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.2B | $1.7B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.3B | $1.5B | ||
| Q4 24 | $1.6B | $1.8B | ||
| Q3 24 | $1.7B | $2.2B | ||
| Q2 24 | $1.8B | $3.2B | ||
| Q1 24 | $1.4B | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | — |
| 自由现金流率自由现金流/营收 | -28.2% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | -2.25× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $-250.2M | — |
8季度趋势，按日历期对齐
经营现金流NVAXRILY
| Q4 25 | $-39.5M | $26.2M | ||
| Q3 25 | $107.8M | $-60.6M | ||
| Q2 25 | $-127.5M | $-25.6M | ||
| Q1 25 | $-185.5M | $184.0K | ||
| Q4 24 | $-87.3M | $-2.7M | ||
| Q3 24 | $-144.8M | $19.5M | ||
| Q2 24 | $314.3M | $111.5M | ||
| Q1 24 | $-83.6M | $135.4M |
自由现金流NVAXRILY
| Q4 25 | $-41.6M | — | ||
| Q3 25 | $105.8M | — | ||
| Q2 25 | $-127.7M | — | ||
| Q1 25 | $-186.7M | — | ||
| Q4 24 | $-100.3M | — | ||
| Q3 24 | $-146.2M | — | ||
| Q2 24 | $311.4M | — | ||
| Q1 24 | $-90.4M | — |
自由现金流率NVAXRILY
| Q4 25 | -28.2% | — | ||
| Q3 25 | 150.2% | — | ||
| Q2 25 | -53.4% | — | ||
| Q1 25 | -28.0% | — | ||
| Q4 24 | -113.6% | — | ||
| Q3 24 | -173.0% | — | ||
| Q2 24 | 74.9% | — | ||
| Q1 24 | -96.4% | — |
资本支出强度NVAXRILY
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 14.8% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 7.3% | — |
现金转化率NVAXRILY
| Q4 25 | -2.25× | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | -1.20× | -0.18× | ||
| Q1 25 | -0.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
